• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

CB 1954的生物活化:活性4-羟基氨基衍生物与硫酯反应形成最终的DNA-DNA链间交联物种。

Bioactivation of CB 1954: reaction of the active 4-hydroxylamino derivative with thioesters to form the ultimate DNA-DNA interstrand crosslinking species.

作者信息

Knox R J, Friedlos F, Marchbank T, Roberts J J

机构信息

Molecular Pharmacology Unit, Institute of Cancer Research, Sutton, Surrey, U.K.

出版信息

Biochem Pharmacol. 1991 Oct 9;42(9):1691-7. doi: 10.1016/0006-2952(91)90503-w.

DOI:10.1016/0006-2952(91)90503-w
PMID:1930294
Abstract

5-(Aziridin-1-yl)-4-hydroxylamino-2-nitrobenzamide is the active form of CB 1954 (5-(aziridin-1-yl)-2,4-dinitrobenzamide). This hydroxylamine is formed by the bioreduction of CB 1954 by the enzyme DT diaphorase and accounts for the highly selective cytotoxicity of this compound. The reason why the hydroxylamine derivative is so cytotoxic is that, in contrast to CB 1954, it can react difunctionally as characterized by the formation of DNA-DNA interstrand crosslinks in cells treated by this agent. However, although the 4-hydroxylamine compound can produce these crosslinks in cells it cannot crosslink naked DNA (Knox et al., Biochem Pharmacol 37: 4661-4669, 1988). We show here that 5-(aziridin-1-yl)-4-hydroxylamino-2-nitrobenzamide can become a species capable of binding to DNA and producing interstrand crosslinks, by a direct, non-enzymatic reaction with either acetyl coenzyme A, butyl and propyl coenzyme A or S-acetylthiocholine. Coenzyme A itself cannot produce these effects. The major product of the reaction between the 4-hydroxylamine and thioesters was identified as 4-amino-5-(aziridin-1-yl)-2-nitrobenzamide. However, this compound is not capable of producing the above effects and the major DNA reactive species was a minor product of the reaction. It is proposed that the ultimate, DNA reactive, derivative of CB 1954 is 4-(N-acetoxy)-5-(aziridin-1-yl)-2-nitrobenzamide.

摘要

5-(氮丙啶-1-基)-4-羟氨基-2-硝基苯甲酰胺是CB 1954(5-(氮丙啶-1-基)-2,4-二硝基苯甲酰胺)的活性形式。这种羟胺是由DT黄递酶对CB 1954进行生物还原形成的,它是该化合物具有高选择性细胞毒性的原因。羟胺衍生物具有如此高细胞毒性的原因是,与CB 1954不同,它可以以双功能方式反应,其特征是在用该试剂处理的细胞中形成DNA-DNA链间交联。然而,尽管4-羟胺化合物可以在细胞中产生这些交联,但它不能使裸露的DNA交联(诺克斯等人,《生化药理学》37:4661-4669,1988)。我们在此表明,5-(氮丙啶-1-基)-4-羟氨基-2-硝基苯甲酰胺可通过与乙酰辅酶A、丁酰辅酶A、丙酰辅酶A或S-乙酰硫代胆碱直接发生非酶反应,变成能够与DNA结合并产生链间交联的物质。辅酶A本身不能产生这些效应。4-羟胺与硫酯反应的主要产物被鉴定为4-氨基-5-(氮丙啶-1-基)-2-硝基苯甲酰胺。然而,该化合物不能产生上述效应,主要的DNA反应性物质是该反应的次要产物。有人提出,CB 1954的最终DNA反应性衍生物是4-(N-乙酰氧基)-5-(氮丙啶-1-基)-2-硝基苯甲酰胺。

相似文献

1
Bioactivation of CB 1954: reaction of the active 4-hydroxylamino derivative with thioesters to form the ultimate DNA-DNA interstrand crosslinking species.CB 1954的生物活化:活性4-羟基氨基衍生物与硫酯反应形成最终的DNA-DNA链间交联物种。
Biochem Pharmacol. 1991 Oct 9;42(9):1691-7. doi: 10.1016/0006-2952(91)90503-w.
2
A new cytotoxic, DNA interstrand crosslinking agent, 5-(aziridin-1-yl)-4-hydroxylamino-2-nitrobenzamide, is formed from 5-(aziridin-1-yl)-2,4-dinitrobenzamide (CB 1954) by a nitroreductase enzyme in Walker carcinoma cells.
Biochem Pharmacol. 1988 Dec 15;37(24):4661-9. doi: 10.1016/0006-2952(88)90335-8.
3
Caffeine, aminoimidazolecarboxamide and dicoumarol, inhibitors of NAD(P)H dehydrogenase (quinone) (DT diaphorase), prevent both the cytotoxicity and DNA interstrand crosslinking produced by 5-(aziridin-1-yl)-2,4-dinitrobenzamide (CB 1954) in Walker cells.
Biochem Pharmacol. 1989 Nov 15;38(22):4137-43. doi: 10.1016/0006-2952(89)90695-3.
4
The differences in kinetics of rat and human DT diaphorase result in a differential sensitivity of derived cell lines to CB 1954 (5-(aziridin-1-yl)-2,4-dinitrobenzamide).
Biochem Pharmacol. 1991;41(6-7):867-75. doi: 10.1016/0006-2952(91)90190-g.
5
Identification, synthesis and properties of 5-(aziridin-1-yl)-2-nitro-4-nitrosobenzamide, a novel DNA crosslinking agent derived from CB1954.
Biochem Pharmacol. 1993 Sep 1;46(5):797-803. doi: 10.1016/0006-2952(93)90487-h.
6
The nitroreductase enzyme in Walker cells that activates 5-(aziridin-1-yl)-2,4-dinitrobenzamide (CB 1954) to 5-(aziridin-1-yl)-4-hydroxylamino-2-nitrobenzamide is a form of NAD(P)H dehydrogenase (quinone) (EC 1.6.99.2).
Biochem Pharmacol. 1988 Dec 15;37(24):4671-7. doi: 10.1016/0006-2952(88)90336-x.
7
The bioactivation of CB 1954 and its use as a prodrug in antibody-directed enzyme prodrug therapy (ADEPT).CB 1954的生物活化及其作为前体药物在抗体导向酶前体药物疗法(ADEPT)中的应用。
Cancer Metastasis Rev. 1993 Jun;12(2):195-212. doi: 10.1007/BF00689810.
8
The properties of total adducts and interstrand crosslinks in the DNA of cells treated with CB 1954. Exceptional frequency and stability of the crosslink.用CB 1954处理的细胞DNA中总加合物和链间交联的特性。交联的异常频率和稳定性。
Biochem Pharmacol. 1992 Mar 17;43(6):1249-54. doi: 10.1016/0006-2952(92)90499-9.
9
Bioactivation of 5-(aziridin-1-yl)-2,4-dinitrobenzamide (CB 1954) by human NAD(P)H quinone oxidoreductase 2: a novel co-substrate-mediated antitumor prodrug therapy.人NAD(P)H醌氧化还原酶2对5-(氮丙啶-1-基)-2,4-二硝基苯甲酰胺(CB 1954)的生物活化:一种新型的共底物介导的抗肿瘤前药疗法。
Cancer Res. 2000 Aug 1;60(15):4179-86.
10
The bioactivation of 5-(aziridin-1-yl)-2,4-dinitrobenzamide (CB1954)--II. A comparison of an Escherichia coli nitroreductase and Walker DT diaphorase.5-(氮丙啶-1-基)-2,4-二硝基苯甲酰胺(CB1954)的生物活化作用——II. 大肠杆菌硝基还原酶与沃克DT黄递酶的比较
Biochem Pharmacol. 1992 Dec 15;44(12):2297-301. doi: 10.1016/0006-2952(92)90672-6.

引用本文的文献

1
The dinitrobenzamide mustard prodrugs, PR-104A and SN27686, for use in a novel MNDEPT cancer prodrug therapy approach.用于新型 MNDEPT 癌症前药治疗方法的二硝基苯甲酰胺前药 PR-104A 和 SN27686。
Biosci Rep. 2023 Apr 26;43(4). doi: 10.1042/BSR20230627.
2
The Crystal Structure of Engineered Nitroreductase NTR 2.0 and Impact of F70A and F108Y Substitutions on Substrate Specificity.工程化硝基还原酶 NTR 2.0 的晶体结构及 F70A 和 F108Y 取代对底物特异性的影响。
Int J Mol Sci. 2023 Apr 1;24(7):6633. doi: 10.3390/ijms24076633.
3
Engineering the Nitroreductase NfsA to Create a Flexible Enzyme-Prodrug Activation System.
工程改造硝基还原酶NfsA以创建一个灵活的酶-前药激活系统。
Front Pharmacol. 2021 Jun 7;12:701456. doi: 10.3389/fphar.2021.701456. eCollection 2021.
4
The YfkO Nitroreductase from Bacillus Licheniformis on Gold-Coated Superparamagnetic Nanoparticles: Towards a Novel Directed Enzyme Prodrug Therapy Approach.来自地衣芽孢杆菌的YfkO硝基还原酶负载于金包被超顺磁性纳米颗粒上:迈向一种新型的定向酶前药治疗方法。
Pharmaceutics. 2021 Apr 9;13(4):517. doi: 10.3390/pharmaceutics13040517.
5
Evaluation of two xenobiotic reductases from Pseudomonas putida for their suitability for magnetic nanoparticle-directed enzyme prodrug therapy as a novel approach to cancer treatment.评价两种来自恶臭假单胞菌的异种生物还原酶,以评估其作为癌症治疗新方法的磁性纳米颗粒导向酶前药治疗的适用性。
Microbiologyopen. 2020 Oct;9(10):e1110. doi: 10.1002/mbo3.1110. Epub 2020 Sep 26.
6
Trypanocidal activity of aziridinyl nitrobenzamide prodrugs.氮芥亚硝基苯甲酰胺前药的抗锥虫活性。
Antimicrob Agents Chemother. 2010 Oct;54(10):4246-52. doi: 10.1128/AAC.00800-10. Epub 2010 Aug 2.
7
E. coli NfsA: an alternative nitroreductase for prodrug activation gene therapy in combination with CB1954.大肠杆菌NfsA:一种与CB1954联合用于前药激活基因治疗的替代硝基还原酶。
Br J Cancer. 2009 Jun 16;100(12):1903-11. doi: 10.1038/sj.bjc.6605094. Epub 2009 May 19.
8
2-Amino metabolites are key mediators of CB 1954 and SN 23862 bystander effects in nitroreductase GDEPT.2-氨基代谢产物是CB 1954和SN 23862在硝基还原酶基因导向酶解药物前体疗法中旁观者效应的关键介质。
Br J Cancer. 2004 Mar 8;90(5):1084-92. doi: 10.1038/sj.bjc.6601612.
9
Professor Tom Connors and the development of novel cancer therapies by the Phase I/II Clinical Trials Committee of Cancer Research UK.汤姆·康纳斯教授与英国癌症研究中心I/II期临床试验委员会新型癌症疗法的研发。
Br J Cancer. 2003 Aug 4;89(3):437-54. doi: 10.1038/sj.bjc.6601106.
10
Prodrugs for Gene-Directed Enzyme-Prodrug Therapy (Suicide Gene Therapy).用于基因导向酶-前药疗法(自杀基因疗法)的前体药物。
J Biomed Biotechnol. 2003;2003(1):48-70. doi: 10.1155/S1110724303209098.